Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 32140709)

  • 1. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42.
    Wang X; Zhang X; Sun J; Sun Y; Zhang Y; He L; Wang P; Li F; Sun C
    Toxicol Appl Pharmacol; 2023 May; 467():116492. PubMed ID: 36977438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.
    Yothaisong S; Thanee M; Namwat N; Yongvanit P; Boonmars T; Puapairoj A; Loilome W
    Asian Pac J Cancer Prev; 2014; 15(23):10463-8. PubMed ID: 25556493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
    Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
    Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic activity of retinoic acid receptor γ is exhibited through activation of the Akt/NF-κB and Wnt/β-catenin pathways in cholangiocarcinoma.
    Huang GL; Luo Q; Rui G; Zhang W; Zhang QY; Chen QX; Shen DY
    Mol Cell Biol; 2013 Sep; 33(17):3416-25. PubMed ID: 23798555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.
    Loilome W; Bungkanjana P; Techasen A; Namwat N; Yongvanit P; Puapairoj A; Khuntikeo N; Riggins GJ
    Tumour Biol; 2014 Jun; 35(6):5357-67. PubMed ID: 24549785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
    Shen DY; Zhang W; Zeng X; Liu CQ
    Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
    Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
    Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of β-catenin activity by luteolin isolated from Paulownia flowers leads to growth arrest and apoptosis in cholangiocarcinoma.
    Yang H; Zhao Y; Song W; Fan G
    Int J Biol Macromol; 2024 Jan; 254(Pt 1):127627. PubMed ID: 37884243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway.
    Cheng H; Li Q
    BMC Gastroenterol; 2023 Aug; 23(1):279. PubMed ID: 37568083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma.
    Kang PC; Leng KM; Liu YP; Liu Y; Xu Y; Qin W; Gao JJ; Wang ZD; Tai S; Zhong XY; Cui YF
    Cell Physiol Biochem; 2018; 49(5):1933-1942. PubMed ID: 30235453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs.
    Sanchon-Sanchez P; Briz O; Macias RIR; Abad M; Sanchez-Martin A; Marin JJG; Lozano E
    Biomed Pharmacother; 2023 Dec; 168():115658. PubMed ID: 37832404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway.
    Shi Z; Zhou L; Zhou Y; Jia X; Yu X; An X; Han Y
    BMB Rep; 2022 Jun; 55(6):299-304. PubMed ID: 35651328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
    Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
    Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.
    Liu J; Han G; Liu H; Qin C
    PLoS One; 2013; 8(4):e62844. PubMed ID: 23646150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Wang Y; Yu H; Xie X; Deng T; Ye L; Wu L; Ding X; Yang Z; Zhu Q; Li J; Zheng Y; Yu Z; Chen G
    Oncogene; 2021 Jun; 40(25):4324-4337. PubMed ID: 34079085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity.
    Lozano E; Sanchon-Sanchez P; Morente-Carrasco A; Chinchilla-Tábora LM; Mauriz JL; Fernández-Palanca P; Marin JJG; Macias RIR
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.